| scholarly article | Q13442814 |
| P2093 | author name string | Xu Zhang | |
| Wei Du | |||
| Zhen Wan | |||
| P2860 | cites work | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis | Q27852988 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3. | Q33705644 | ||
| miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer. | Q35794952 | ||
| Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches | Q38349665 | ||
| Breast cancer risk and clinical implications for germline PTEN mutation carriers | Q38677932 | ||
| Cancer treatment and survivorship statistics, 2016. | Q38859236 | ||
| Prostate cancer, PI3K, PTEN and prognosis | Q39069259 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression | Q40309143 | ||
| The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma | Q40596882 | ||
| The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice | Q42797725 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer. | Q47435142 | ||
| PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy | Q47748552 | ||
| Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013. | Q47898285 | ||
| MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. | Q52671363 | ||
| microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. | Q55252304 | ||
| MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis | Q57458207 | ||
| MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway | Q57470595 | ||
| MicroRNA-645 represses hepatocellular carcinoma progression by inhibiting SOX30-mediated p53 transcriptional activation | Q57480162 | ||
| miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma | Q57490010 | ||
| Hepatocellular carcinoma | Q58020832 | ||
| SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma | Q58583266 | ||
| Hepatitis B Virus Induces Autophagy to Promote its Replication by the Axis of miR-192-3p-XIAP via NF-κB Signaling | Q59353315 | ||
| miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling | Q59800874 | ||
| miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repression | Q60044774 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma | Q61813187 | ||
| MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells | Q88758532 | ||
| microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis | Q91231335 | ||
| Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma | Q91432940 | ||
| Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway | Q91705525 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | cell migration | Q189092 |
| hepatocellular carcinoma | Q1148337 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 4897-4906 | |
| P577 | publication date | 2019-06-21 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN | |
| P478 | volume | 12 |
Search more.